BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Pharm Country

  FDAAdvisoryCommittee.com to Webcast via TalkPoint the FDA Review of Bayer Corporation and Johnson & Johnson Anti-Clot Drug Rivaroxaban on March 19th

  March 11, 2009

   · 

  2 min read
• Business

  PDL BioPharma, Inc. Elects Frederick Frank and Jody Lindell to Its Board of Directors

  March 11, 2009

   · 

  2 min read
• Policy

  Basilea Pharmaceutica’s Toctino(R) Receives Marketing Authorization in Belgium and Luxemburg

  March 11, 2009

   · 

  5 min read
• PRANA Biotechnology’s PBT2 Prevents Synaptic Loss in Alzheimer’s Disease

  March 11, 2009

   · 

  4 min read
• Business

  Ark Therapeutics: Preliminary Results For The Year Ended 31 December 2008

  March 11, 2009

   · 

  1 min read
• Drug Development

  Molecular Insight Pharmaceuticals, Inc. Receives Special Protocol Assessment Approval From FDA for Phase 2 Trial of Azedra(TM), a Radiotherapeutic to Treat Neuroendocrine Cancer

  March 11, 2009

   · 

  6 min read
• Syrris Further Expands Its Atlas Automated Reactor Series

  March 11, 2009

   · 

  4 min read
• Genetown

  The MathWorks, Inc. Introduces Simbiology 3

  March 11, 2009

   · 

  2 min read
• Noven Pharmaceuticals Inc. to Present At Cowen and Company Health Care Conference

  March 11, 2009

   · 

  1 min read
• Deals

  Dow Chemical Will Buy Rohm and Haas April 1

  March 11, 2009

   · 

  1 min read